Severe cognitive or communication impairments (inability to respond accurately to complete study screening questions or to provide informed consent or assent)
Currently pregnant or expecting to become pregnant in the next 8 weeks Comorbid neurological disorder (Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma, spinal cord injury, cerebral palsy)
Comorbid cancer, currently undergoing chemotherapy or radiation treatment
Received inpatient treatment or was hospitalized for a psychiatric condition and/or alcohol or substance abuse within the past 12 months
Current diagnosis of a terminal illness and/or currently receiving hospice care
History of allergic reaction to adhesives that precludes the use of an adhesive necessary for adherence to activPAL measurement
Uses wheelchair as primary mobility aid outside of home setting
Inability to speak, read, or understand English
Concurrent participation in another rehabilitation intervention research study
Resides more than 50 miles outside of the Twin Cities, Minnesota metropolitan area
Investigator discretion for safety or adherence reasons
Clareo Health | Feasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke
